Business · 04/12/2008Updated: 10/17/2026 · 1 min read

FDA Announces Availability of Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics

The Food and Drug Administration (FDA) has released a document outlining cooperative manufacturing arrangements for licensed biologics, providing information on strategies for meeting the increased need for flexible manufacturing arrangements, and finalizing a draft guidance document dated November 2008.